May 26, 2016 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Monsanto Company (NYSE:MON), was announced concerning whether a takeover of Monsanto Company by Bayer AG at $122 per share would be unfair to NYSE:MON stockholders.

The investigation by a law firm concerns whether certain officers and directors of Monsanto Company breached their fiduciary duties owed to NYSE:MON investors in connection with the proposed acquisition.

On May 18, 2106, St. Louis, MO based Monsanto Company said that in response to recent media reports, it disclosed that it has received an unsolicited, non-binding proposal from Bayer AG for a potential acquisition of Monsanto, subject to due diligence, regulatory approvals and other conditions.
Then on May 23, 2016, Bayer AG said that in response to further market speculation and stakeholder inquiries, it is publicly disclosing the contents of its private proposal to acquire Monsanto. Bayer AG said it has made an all-cash offer to acquire all of the issued and outstanding shares of common stock of Monsanto Company for USD 122 per share or an aggregate value of USD 62 billion.

On May 24, 2016, Monsanto Company rejected the offer by Bayer AG as being incomplete and financially inadequate.

Nevertheless, the investigation concerns whether the Monsanto Board of Directors will undertake an adequate sales process, adequately shop the company before entering into the transaction, maximize shareholder value by negotiating the best price, and act in the shareholders' best interests in connection with the proposed sale.